Dr. Subramanian is a Professor of Medicine at the University of Washington and Medical Director of the UW Lipid Clinic. She is a nationally recognized expert in diabetes and cardiometabolic health, with a strong focus on technology-enabled care. She contributes to major clinical guidelines and leads national education for providers. With deep clinical experience and research leadership, she is exceptionally well qualified to guide decisions about diabetes technology.

Dr. Robert Eckel is the founder of the Lipoprotein Apheresis Program at University of Colorado. Dr. Eckel earned his medical degree from the University of Cincinnati College of Medicine, and completed his residency at University of Wisconsin Hospitals in Madison, and fellowship in Metabolism and Endocrinology at the University of Washington School of Medicine in Seattle. With over 300 articles published in peer reviewed journals, he is also past president of the American Heart Association, Obesity Society, Association of Patient Oriented Research, and of Science & Medicine of the American Diabetes Association. He is a member of the Epidemiology of Diabetes Interventions and Complications and is on the Board of the American Diabetes Association.

Dr. Ganda is the Medical Director of the Lipid Clinic at Joslin Diabetes Center and Associate Professor of Medicine at Harvard. He has been a co-investigator in several NIH-funded clinical trials and several studies about diabetes prevention, triglycerides, and heart disease. Board-certified in internal medicine and endocrinology, he has published over 200 papers. His work focuses on helping people with diabetes better understand and manage important health risks like triglycerides.